2016 / 01

Next Paper
DOI: 10.24075/brsmu.2016-01-04

ORIGINAL RESEARCH

T-cadherin gene polymorphism is associated with ischemic heart disease manifestations

Balatskiy AV1, Chotchaeva FR2, Ivanov AD2, Samokhodskaya LM1, Tkachuk VA2
About authors

1 Medical Science and Education Centre,
Lomonosov Moscow State University, Moscow, Russia

2 Faculty of Fundamental Medicine,
Lomonosov Moscow State University, Moscow, Russia

Correspondence should be addressed: Alexandr Balatskiy
Lomonosovsky prospekt, d. 31, korp. 5, Moscow, Russia, 119192; ur.usm.mbf@ykstalab

Received: 2015-12-29 Accepted: 2016-01-20 Published online: 2017-01-05
|
  1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013 Sep 30; 168 (2): 934–45. DOI: 10.1016/j.ijcard.2012.10.046. PubMed PMID: 23218570; PubMed Central PMCID: PMC3819990.
  2. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 2000 Apr; 149 (2): 251–66. PubMed PMID: 10729375.
  3. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988 Jul; 12 (1): 56–62. PubMed PMID: 3379219.
  4. Kostopoulos CG, Spiroglou SG, Varakis JN, Apostolakis E, Papadaki HH. Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis? Cardiovasc Pathol. 2014 May–Jun; 23 (3): 131–8. DOI: 10.1016/j.carpath.2014.02.003. PubMed PMID: 24675084.
  5. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak E, et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol. 2001 Mar; 115 (3): 231–42. DOI: 10.1007/s004180100252. PubMed PMID: 11326751.
  6. Philippova M, Suter Y, Toggweiler S, Schoenenberger AW, Joshi MB, Kyriakakis E, et al. T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. Eur Heart J. 2011 Mar; 32 (6): 760–71. DOI: 10.1093/eurheartj/ehq206. PubMed PMID: 20584775.
  7. Pfaff D, Schoenenberger AW, Dasen B, Erne P, Resink TJ, Philippova M. Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2015 Oct; 4 (5): 410–8. DOI: 10.1177/2048872614557229. PubMed PMID: 25344491.
  8. Kuzmenko YS, Stambolsky D, Kern F, Bochkov VN, Tkachuk VA, Resink TJ. Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators. Biochem Biophys Res Commun. 1998 May 19; 246 (2): 489–94. DOI: 10.1006/bbrc.1998.8645. PubMed PMID: ISI:000073796900037.
  9. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004 Jul 13; 101 (28): 10308–13. DOI: 10.1073/pnas.0403382101. PubMed PMID: 15210937; PubMed Central PMCID: PMC478568.
  10. Matsuura F, Oku H, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, et al. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem Biophys Res Commun. 2007 Jul 13; 358 (4): 1091–5. DOI: 10.1016/j.bbrc.2007.05.040. PubMed PMID: 17521614.
  11. Nawrocki AR, Hofmann SM, Teupser D, Basford JE, Durand JL, Jelicks LA, et al. Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2010 Jun; 30 (6): 1159–65. DOI: 10.1161/ATVBAHA.109.195826. PubMed PMID: 20299691; PubMed Central PMCID: PMC2896306.
  12. Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2008 Feb 1; 102 (2): 218–25. DOI: 10.1161/CIRCRESAHA.107.164988. PubMed PMID: 17991878.
  13. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001 Feb 27; 103 (8): 1057–63. DOI: 10.1161/01.cir.103.8.1057. PubMed PMID: 11222466.
  14. Ho DY, Cook NR, Britton KA, Kim E, Creager MA, Ridker PM, et al. High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation. Circulation. 2011 Nov 22; 124 (21): 2303–11. DOI: 10.1161/CIRCULATIONAHA.111.045187. PubMed PMID: 22025604; PubMed Central PMCID: PMC3256987.
  15. Joosten MM, Joshipura KJ, Pai JK, Bertoia ML, Rimm EB, Mittleman MA, et al. Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men. Arterioscler Thromb Vasc Biol. 2013 May; 33 (5): 1092–7. DOI: 10.1161/ATVBAHA.112.301089. PubMed PMID: 23448969; PubMed Central PMCID: PMC3685180.
  16. Cai XJ, Chen L, Li L, Feng M, Li X, Zhang K, et al. Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. Mol Endocrinol. 2010 Jan; 24 (1): 218–28. DOI: 10.1210/me.2009-0128. PubMed PMID: 19889816.
  17. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011 Sep; 60 (9): 2417–23. DOI: 10.2337/db10-1321. PubMed PMID: 21771975; PubMed Central PMCID: PMC3161336.
  18. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat. 2012 Feb; 33 (2): 402–10. DOI: 10.1002/humu.21652. PubMed PMID: 22065538.
  19. Jee SH, Sull JW, Lee JE, Shin C, Park J, Kimm H, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010 Oct 8; 87 (4): 545–52. DOI: 10.1016/j.ajhg.2010.09.004. PubMed PMID: 20887962; PubMed Central PMCID: PMCPmc2948810.
  20. Lee JH, Shin DJ, Park S, Kang SM, Jang Y, Lee SH. Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population. Yonsei Med J. 2013 Nov; 54 (6): 1305–12. DOI: 10.3349/ymj.2013.54.6.1305. PubMed PMID: 24142632; PubMed Central PMCID: PMCPmc3809859.
  21. Fava C, Danese E, Montagnana M, Sjögren M, Almgren P, Guidi GC, et al. A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. Am J Cardiol. 2011 Nov 15; 108 (10): 1432–7. DOI: 10.1016/j.amjcard.2011.06.068. PubMed PMID: 21872196.
  22. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet. 2009 Jun 15; 18 (12): 2288–96. DOI: 10.1093/hmg/ddp135. PubMed PMID: 19304780; PubMed Central PMCID: PMC2685752.
  23. Putku M, Kals M, Inno R, Kasela S, Org E, Kožich V, et al. CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs. Hum Genet. 2015 Mar; 134 (3): 291–303. DOI: 10.1007/s00439-014-1521-6. PubMed PMID: 25543204; PubMed Central PMCID: PMC4318987.
  24. Gao H, Kim YM, Chen P, Igase M, Kawamoto R, Kim MK, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes. 2013 Dec; 62 (12): 4277–83. DOI: 10.2337/db13-0129. PubMed PMID: 24009259; PubMed Central PMCID: PMCPmc3837060.
  25. Teng MS, Hsu LA, Wu S, Sun YC, Juan SH, Ko YL. Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect. PloS One. 2015 Apr 13; 10 (4): e0122664. DOI: 10.1371/journal.pone.0122664. PubMed PMID: 25875811; PubMed Central PMCID: PMC4395292.
  26. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006 Aug 1; 22 (15): 1928–9. DOI: 10.1093/bioinformatics/btl268. PubMed PMID: 16720584.
  27. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010 Dec; 120 (12): 4342–52. DOI: 10.1172/JCI43464. PubMed PMID: 21041950; PubMed Central PMCID: PMC2993592.
  28. Shibata R, Sato K, Kumada M, Izumiya Y, Sonoda M, Kihara S, et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res. 2007 Jun 1; 74 (3): 471–9. DOI: 10.1016/j.cardiores.2007.02.010. PubMed PMID: 17362898.
  29. Philippova M, Joshi MB, Pfaff D, Kyriakakis E, Maslova K, Erne P, et al. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells. Cardiovasc Res. 2012 Mar 1; 93 (3): 498–507. DOI: 10.1093/cvr/cvs004. PubMed PMID: 22235028.
  30. Frismantiene A, Pfaff D, Frachet A, Coen M, Joshi MB, Maslova K, et al. Regulation of contractile signaling and matrix remodeling by T-cadherin in vascular smooth muscle cells: constitutive and insulin-dependent effects. Cell Signal. 2014 Sep; 26 (9): 1897–908. DOI: 10.1016/j.cellsig.2014.05.001. PubMed PMID: 24815187.
  31. Schoenenberger AW, Pfaff D, Dasen B, Frismantiene A, Erne P, Resink TJ, et al. Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease. PloS One. 2015 Jun 17; 10 (6): e0131140. DOI: 10.1371/journal.pone.0131140. PubMed PMID: 26083608; PubMed Central PMCID: PMC4470588.